AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 520100
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg/d)
Trial: 520100
Drug: Naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (750 mg/d)
Trial: 520100
Drug: Ibuprofen (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (1600 mg/d)
Trial: 520100
Drug: Ibuprofen (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (2400 mg/d)
Trial: 22154397
Drug: Concurrent training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent training (ER, n = 10)
Trial: 20885293
Drug: Sugammadex (0.22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (0.22 mg/kg)
Trial: 20885293
Drug: Neostigmine (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (34 μg/kg)
Trial: 17508624
Drug: Oral-B Pulsar
RxNorm normalized name: Oral-B Pulsar 3D White Luxe Pulsar Toothbrush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Pulsar (PUL)
Trial: 17508624
Drug: Oral-B Advantage
RxNorm normalized name: Advantage Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B Advantage Plus (AP)
Trial: 17508624
Drug: Oral-B CrossAction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B CrossAction (CA)
Trial: 17508624
Drug: Oral-B CrossAction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-B CrossAction Power (CAP)
Trial: 10077031
Drug: OptiMARK (gadoversetamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OptiMARK (gadoversetamide injection) 0.1 mmol/kg
Trial: 10077031
Drug: OptiMARK (gadoversetamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OptiMARK (gadoversetamide injection) 0.3 mmol/kg
Trial: 10077031
Drug: OptiMARK (gadoversetamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OptiMARK (gadoversetamide injection) 0.5 mmol/kg
Trial: 7324833
Drug: oxycodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxycodone (10 mg)
Trial: 30777086
Drug: AZD7594 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD7594 800 μg
Trial: 30777086
Drug: AZD7594 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD7594 250 μg
Trial: 30777086
Drug: AZD7594 58
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD7594 58 μg
Trial: 30777086
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of AZD7594
Trial: 29103052
Drug: Isradipine as
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine as a disease modifying agent for PD
Trial: 25827292
Drug: Early enteral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early enteral feeding (intraoperative nasojejunal tube placement and enteral feeding until adequate oral intake could be maintained)
Trial: 21059817
Drug: Methylphenidate (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (0, 10, 20, and 40 mg)
Trial: 17530638
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no bosentan treatment)
Trial: 15238592
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein containing 99 mg of isoflavones (25.6 g daily for 12 months)
Trial: 9489580
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapies
Trial: 8194505
Drug: Zinc with
RxNorm normalized name: Zinc with Vitamin C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc with 600 mg elemental calcium as calcium carbonate
Trial: 8194505
Drug: Zinc with
RxNorm normalized name: Zinc with Vitamin C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc with 600 mg elemental calcium as calcium citrate
Trial: 3651528
Drug: RS 86
RxNorm normalized name: (RS)-bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RS 86 (oral, long-acting muscarinic agonist)
Trial: 27900813
Drug: 2% sevoflurane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% sevoflurane at 1 l·min‐1 fresh gas flow [O2 : N2 O = 50 : 50]
Trial: 27900813
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow reduced to 0.5 l·min‐1 [O2 : N2 O = 50 : 50] (control group)
Trial: 25840693
Drug: Ipilimumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipilimumab (10 mg/kg, intravenous infusions every 3 weeks for four doses, then every 3 months for up to 3 years)
Trial: 16776756
Drug: ProFile .04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ProFile .04 taper rotary instruments
Trial: 9375949
Drug: Metoprolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (15 mg IV divided into 3 injections, then 200 mg orally daily for 3 months)
Trial: 1492579
Drug: Progesterone solution
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone solution in almond oil, 2 mg/0.1 ml (total dose approximately 11 mg)
Trial: 1492579
Drug: Progesterone solution
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone solution in dimethicone, 5 mg/0.1 ml (total dose approximately 28 mg)
Trial: 30006308
Drug: Questions about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Questions about symptoms and hypoglycaemia treatment
Trial: 23778343
Drug: Saint John's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saint John's wort (300 mg daily for three months)
Trial: 18791717
Drug: Tocosol Paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocosol Paclitaxel (175 mg/m², 15 min infusion)
Trial: 18791717
Drug: Taxol (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxol (175 mg/m², 3 h infusion)
Trial: 17348991
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% N-acetyl glucosamine (NAG)
Trial: 17348991
Drug: Topical combination
RxNorm normalized name: soap TOPICAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical combination of 2% N-acetyl glucosamine (NAG) with 4% niacinamide
Trial: 11518072
Drug: Jarsin 300
RxNorm normalized name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [ILIA SUPER SERUM SKIN TINT (ST16.5 JARDIN)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jarsin 300 (9 tablets)
Trial: 11518072
Drug: Ketanserin (5‐HT2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (5‐HT2 receptor antagonist)
Trial: 11518072
Drug: WAY‐100635 (5‐HT1A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WAY‐100635 (5‐HT1A antagonist)
Trial: 7841729
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of racemic adrenaline
Trial: 2905636
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg glafenine
Trial: 23840296
Drug: Sodium Ferulate
RxNorm normalized name: ferulate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium Ferulate (SF) pretreatment for 14 days with bupropion (150 mg)
Trial: 14643034
Drug: 200 microg
RxNorm normalized name: Digoxin 200 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg oral misoprostol
Trial: 9024268
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17-beta-estradiol orally for 3 months (with 1 mg norethisterone acetate added for 10 days during the last 16 days for endometrial protection)
Trial: 3305221
Drug: Myelosuppressive postinduction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myelosuppressive postinduction treatment
Trial: 3305221
Drug: Monthly maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly maintenance chemotherapy
Trial: 3305221
Drug: Intensive two-course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive two-course preremission therapy
Trial: 26699899
Drug: Atorvastatin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (initial dose of 40 mg at admission followed by 10 mg/day for 30 days)
Trial: 21916603
Drug: Low vitamin
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low vitamin D status (serum 25-hydroxyvitamin D < 32 ng/mL)
Trial: 8417634
Drug: Glipizide 20
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide 20 mg
Trial: 8417634
Drug: Glipizide 40
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide 40 mg
Trial: 3777463
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic solution with hyaluronidase (75 international units diluted in 5 ml of local anesthetic mixture)
Trial: 3777463
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic solution without hyaluronidase
Trial: 29558953
Drug: Gum Arabic
RxNorm normalized name: Gum arabic
DrugBank: Acacia (DB10451)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gum Arabic (30 g daily for 3 months)
Trial: 29558953
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 g daily for 3 months)
Trial: 25066102
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavior therapy (ICBT) with booster program
Trial: 25066102
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavior therapy (ICBT) without booster program
Trial: 20084409
Drug: Caudal blockade
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal blockade with 0.5% bupivacaine [10 ml x height (m)]
Trial: 19453397
Drug: FluBlok, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FluBlok, a recombinant trivalent hemagglutinin vaccine
Trial: 19453397
Drug: Traditional egg-based
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional egg-based trivalent inactivated influenza vaccine (TIV)
Trial: 15935019
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate 200 mg
Trial: 8676421
Drug: VO2I >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VO2I > or = 150 or DO2I > or = 600 mL/min/m2 (Group 1)
Trial: 1804599
Drug: Ceftriaxone 2
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 2 g once daily + Amikacin 0.5 g
Trial: 1804599
Drug: Ceftazidime 2
RxNorm normalized name: ceftazidime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 2 g twice daily + Amikacin 0.5 g b.i.d.
Trial: 6097173
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g of sulbactam given in a single intramuscular dose with 1.0 g of probenecid orally
Trial: 6097173
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of intramuscular sulbactam given twice, 4 h apart
Trial: 18525042
Drug: Hypothermia therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermia therapy (32.5 degrees C for 24 hours)
Trial: 7085368
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (cefazolin or carbenicillin, three perioperative doses)
Trial: 23394404
Drug: Drug-eluting balloon
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloon (Sequent please; B. Braun) followed by bare metal stent (Coroflex Blue; B. Braun)
Trial: 23394404
Drug: Drug-eluting stent
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stent (Resolute Integrity; Boston Scientific)
Trial: 21247998
Drug: ondansetron (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (4 μg/kg twice daily)
Trial: 11593458
Drug: Videotape preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Videotape preparation before hip replacement surgery
Trial: 11593458
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no videotape preparation)
Trial: 11593458
Drug: Videotape preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Videotape preparation
Trial: 125133
Drug: Methandienone 10
RxNorm normalized name: Metandienone
DrugBank: Metandienone (DB13586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methandienone 10 mg/day
Trial: 125133
Drug: Methandienone 25
RxNorm normalized name: Metandienone
DrugBank: Metandienone (DB13586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methandienone 25 mg/day
Trial: 28286189
Drug: Dried aqueous
RxNorm normalized name: peptone,dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dried aqueous spearmint extract (600 mg/day) for 90 days
Trial: 28286189
Drug: Dried aqueous
RxNorm normalized name: peptone,dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dried aqueous spearmint extract (900 mg/day) for 90 days
Trial: 17538539
Drug: 1.6 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g/day of plant sterols (PS) for 3 weeks
Trial: 17538539
Drug: 3.0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g/day of plant sterols (PS) for 3 weeks
Trial: 17511685
Drug: Steroid (methylprednisolon)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Steroid (methylprednisolon)
Trial: 11688766
Drug: Nifedipine gastrointestinal
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine gastrointestinal therapeutic system (NI) 30-60 mg once a day
Trial: 11688766
Drug: Amlodipine (AM)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AM) 5-10 mg once a day
Trial: 7837683
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (omeprazole 20mg once daily)
Trial: 7837683
Drug: H2-blocker (famotidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-blocker (famotidine 20mg twice daily)
Trial: 3045781
Drug: Dicloxacillin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dicloxacillin (25 mg/kg/day for 10 days)
Trial: 24912561
Drug: Rehabilitation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation treatment which did not include training of sensory strategies
Trial: 20509752
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg b.i.d. + Amoxicillin 1000 mg + Clarithromycin 500 mg for 1 week followed by placebo for 3 weeks
Trial: 20509752
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg b.i.d. + Placebo antibiotics for 1 week followed by Esomeprazole 20 mg o.d. for 3 weeks
Trial: 20509752
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg o.d. after initial treatment
Trial: 16035144
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 45 mg
Trial: 12236071
Drug: Sustained-release sparfloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release sparfloxacin chip (SRS chip)
Trial: 7669991
Drug: Tetrahydroaminoacridine 75
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine 75 mg
Trial: 7669991
Drug: Tetrahydroaminoacridine 25
RxNorm normalized name: Tetrahydroaminoacridine
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydroaminoacridine 25 mg
Trial: 1823750
Drug: Hydrochlorothiazide, 25
RxNorm normalized name: HydroCHLOROthiazide, 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide, 25 mg/day
Trial: 7193918
Drug: i.v. DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. DDAVP (0.1‐0.4 μg/Kg)
Trial: 7193918
Drug: i.n. DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.n. DDAVP (1‐4 μg/Kg)
Trial: 7193918
Drug: i.v. DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. DDAVP (0.4 μg/Kg) single dose
Trial: 7193918
Drug: i.v. DDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. DDAVP (0.4 μg/Kg) repeated doses
Trial: 28684276
Drug: Capsaicin (100µg/50µl)
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin (100µg/50µl) administered into ST36 or ST37 acupoint
Trial: 28684276
Drug: Capsaicin administered
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin administered into ST36 acupoint
Trial: 28684276
Drug: Pre-emptive treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-emptive treatment of contralateral ST36 acupoint with 43°C heating-needle stimulation
Trial: 28684276
Drug: Non-acupoint area
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-acupoint area treatment
Trial: 25976567
Drug: S-line blood-liquid
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-line blood-liquid warmer with Mediset infusion set
Trial: 12008788
Drug: Pleconaril 400
RxNorm normalized name: pleconaril
DrugBank: Pleconaril (DB05105)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pleconaril 400 mg three-times daily for 7 days
Trial: 12008788
Drug: Pleconaril 400
RxNorm normalized name: pleconaril
DrugBank: Pleconaril (DB05105)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pleconaril 400 mg three-times daily
Trial: 2569485
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg acetaminophen plus 60 mg phenyltoloxamine citrate
Trial: 2569485
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg acetaminophen alone
Trial: 28644243
Drug: No‐MASK +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No‐MASK + O2 (10 l/min of oxygen via nasal cannula)
Trial: 27039086
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (10 sessions of real acupuncture)
Trial: 17323786
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg nebivolol PO (n = 10)
Trial: 17323786
Drug: metoprolol tartrate
RxNorm normalized name: Metoprolol Tartrate
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: metoprolol tartrate 50 mg PO (n = 10)
Trial: 15481851
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate 1,350 mg/day
Trial: 15481851
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate 2,250 mg/day
Trial: 15481851
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate (all doses)
Trial: 11479411
Drug: Oral inoculation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral inoculation with 106 viable cells of plasmid-free human E. coli within 2 hours after birth
Trial: 11479411
Drug: Oral inoculation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral inoculation with 106 viable cells of plasmid-free human E. coli
Trial: 3262598
Drug: Ascorbate (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ascorbate (3 grams daily for 14 days)
Trial: 28961848
Drug: Dacarbazine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacarbazine (1000 mg/m2 every 3 weeks)
Trial: 23081873
Drug: Single-dose systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose systemic methotrexate (MTX)
Trial: 19049696
Drug: Emtricitabine/Tenofovir DF
RxNorm normalized name: COBICISTAT/ELVITEGRAVIR/EMTRICITABINE/TENOFOVIR DF TAB,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emtricitabine/Tenofovir DF (200/300 mg q.d.)
Trial: 19049696
Drug: Tacrolimus (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus (0.1 mg/kg/day)
Trial: 19049696
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Emtricitabine/Tenofovir DF and Tacrolimus
Trial: 16971718
Drug: Preoperative radiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiotherapy and postoperative chemotherapy
Trial: 16971718
Drug: Preoperative chemoradiotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemoradiotherapy and postoperative chemotherapy
Trial: 16971718
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy adherence